Literature DB >> 26271189

Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.

Siddhartha Maity1, Biswanath Sa2.   

Abstract

This work was envisaged to develop compression-coated tablets using a blend of Ca(+2) ion cross-linked carboxymethyl xanthan gum (CMXG) and sodium alginate (SAL) for delayed release of immediate pulse release tablets of prednisolone (PDL) in the colon without the need of colonic bacterial intervention for degradation of the polysaccharide coat. The core tablets containing PDL and other compatible excipients were prepared by direct compression method and subsequently compression coated with different ratios of CMXG and SAL. Long T lag, the time required to restrict the drug release below 10%, and short T rap, the time required for immediate release following the T lag, were considered as suitable release parameters for evaluation of colon targeting of PDL tablets. Among the various compression coats, a blend of CMXG and SAL in a ratio of 1.5:3.5 provided T lag of 5.12 ± 0.09 h and T rap of 6.50 ± 0.05 h. The increase in microcrystalline cellulose (MCC) and crospovidone (CP) in the core tablets did not change T lag significantly although decreased the T rap marginally. Inclusion of an osmogen in the core tablets decreased the T lag to 4.05 ± 0.08 h and T rap to 3.56 ± 0.06 h. The increase in coat weight to 225 mg provided a reasonably long T lag (6.06 ± 0.09 h) and short T rap (4.36 ± 0.20 h). Drug release from most of the formulations followed the Hixson-Crowell equation and sigmoidal pattern as confirmed by the Weibull equation. In conclusion, tablets, compression coated with CMXG and SAL in a ratio of 1.5:3.5 and having 225-mg coat weight, were apparently found suitable for colon targeting.

Entities:  

Keywords:  colon targeting; compression coating; drug release; prednisolone; release kinetic

Mesh:

Substances:

Year:  2015        PMID: 26271189      PMCID: PMC4984885          DOI: 10.1208/s12249-015-0359-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  30 in total

Review 1.  Microbially triggered drug delivery to the colon.

Authors:  V R Sinha; Rachna Kumria
Journal:  Eur J Pharm Sci       Date:  2003-01       Impact factor: 4.384

2.  Development of pulsatile release tablets with swelling and rupturable layers.

Authors:  Srisagul Sungthongjeen; Satit Puttipipatkhachorn; Ornlaksana Paeratakul; Andrei Dashevsky; Roland Bodmeier
Journal:  J Control Release       Date:  2004-03-05       Impact factor: 9.776

3.  Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.

Authors:  Soravoot Rujivipat; Roland Bodmeier
Journal:  Eur J Pharm Biopharm       Date:  2010-09-22       Impact factor: 5.571

4.  In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.

Authors:  V R Sinha; B R Mittal; Rachna Kumria
Journal:  Int J Pharm       Date:  2004-12-25       Impact factor: 5.875

5.  Immersion coating of pellets with calcium pectinate and chitosan.

Authors:  Marianne Hiorth; Therese Versland; Juha Heikkilä; Ingunn Tho; Sverre Arne Sande
Journal:  Int J Pharm       Date:  2005-12-01       Impact factor: 5.875

6.  Ca-carboxymethyl xanthan gum mini-matrices: Swelling, erosion and their impact on drug release mechanism.

Authors:  Siddhartha Maity; Biswanath Sa
Journal:  Int J Biol Macromol       Date:  2014-04-24       Impact factor: 6.953

7.  Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets.

Authors:  Wycliffe Omwancha; Chahinaz Kouba; Satish Yelamanchili; Steven H Neau
Journal:  Drug Dev Ind Pharm       Date:  2011-03-21       Impact factor: 3.225

8.  Swelling and erosion of pectin matrix tablets and their impact on drug release behavior.

Authors:  Pornsak Sriamornsak; Nartaya Thirawong; Yossanun Weerapol; Jurairat Nunthanid; Srisagul Sungthongjeen
Journal:  Eur J Pharm Biopharm       Date:  2006-12-28       Impact factor: 5.571

9.  Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.

Authors:  Sateesh Kumar Vemula; Prabhakar Reddy Veerareddy; Venkat Ratnam Devadasu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-11       Impact factor: 2.441

10.  Colon targeted guar gum compression coated tablets of flurbiprofen: formulation, development, and pharmacokinetics.

Authors:  Sateesh Kumar Vemula; Vijaya Kumar Bontha
Journal:  Biomed Res Int       Date:  2013-10-24       Impact factor: 3.411

View more
  5 in total

1.  An Integrative QbD Approach for the Development and Optimization of Controlled Release Compressed Coated Formulation of Water-Soluble Drugs.

Authors:  Viral Shah; Ekta Khambhla; Manish Nivsarkar; Riddhi Trivedi; Rakesh K Patel
Journal:  AAPS PharmSciTech       Date:  2022-04-22       Impact factor: 3.246

2.  In Vitro and In Vivo Correlation of Colon-Targeted Compression-Coated Tablets.

Authors:  Siddhartha Maity; Amit Kundu; Sanmoy Karmakar; Biswanath Sa
Journal:  J Pharm (Cairo)       Date:  2016-02-17

3.  Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.

Authors:  Chao Li; Kaixiang Zhou; Dongmei Chen; Wei Xu; Yanfei Tao; Yuanhu Pan; Kuiyu Meng; Muhammad Abu Bakr Shabbir; Qianying Liu; Lingli Huang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2019-03-01

Review 4.  Xanthan gum derivatives: review of synthesis, properties and diverse applications.

Authors:  Jwala Patel; Biswajit Maji; N S Hari Narayana Moorthy; Sabyasachi Maiti
Journal:  RSC Adv       Date:  2020-07-21       Impact factor: 4.036

5.  Magnetic hyperthermia controlled drug release in the GI tract: solving the problem of detection.

Authors:  Joseph C Bear; P Stephen Patrick; Alfred Casson; Paul Southern; Fang-Yu Lin; Michael J Powell; Quentin A Pankhurst; Tammy Kalber; Mark Lythgoe; Ivan P Parkin; Andrew G Mayes
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.